ARTICLE | Clinical News
Tagrisso: Additional Ph III AURA3 data
December 9, 2016 5:14 PM UTC
Additional data from the open-label, international Phase III AURA3 trial in 419 patients with EGFR T790M mutation-positive, locally advanced or metastatic NSCLC whose disease progressed following firs...
BCIQ Company Profiles
BCIQ Target Profiles